Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Will Consult With USTR On Patent Relief Claims From Foreign Countries

Executive Summary

HHS will have a formal consulting role in future decisions by the U.S. Trade Representative about claims from foreign governments that patent laws hinder their ability to address a public health emergency.

You may also be interested in...



HHS Human Subject Protection Team Will Include Former FDAer Nightingale

Former FDA Associate Commissioner for Health Affairs Stuart Nightingale, MD, will work on human subject protection issues as one of his responsibilities in a new position at HHS.

HHS Human Subject Protection Team Will Include Former FDAer Nightingale

Former FDA Associate Commissioner for Health Affairs Stuart Nightingale, MD, will work on human subject protection issues as one of his responsibilities in a new position at HHS.

Africa AIDS Drug Program Relies On NGOs To Achieve Secure Distribution

Five of the major AIDS drug marketers are counting on the leading non-governmental organizations to develop secure distribution systems for drugs supplied to developing countries.

Related Content

UsernamePublicRestriction

Register

OM007016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel